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ABSTRACT
Objectives: To examine the hypothesis that the use of a wash product formulated for newborn (<1 month of age)
bathing is not inferior (no worse) to bathing with water only.
Design: Assessor-blinded, randomized, controlled, noninferiority trial.
Setting: A teaching hospital in the Northwest of England and in participants’ homes.
Participants: Three-hundred-and-seven healthy, term infants recruited within 48 hours of birth.
Method: We compared bathing with a wash product (n = 159) to bathing with water alone (n = 148). The primary out-
come was transepidermal water loss (TEWL) at 14 days postbirth; the predefined difference deemed to be unimportant
was 1.2. Secondary outcomes comprised changes in stratum corneum hydration, skin surface pH, clinical observations
of the skin, and maternal views.
Results: Complete TEWL data were obtained for 242 (78.8%) infants. Wash was noninferior to water alone in terms of
TEWL (intention-to-treat analysis: 95% confidence interval [CI] for difference [wash–water, adjusted for family history of
eczema, neonate state, and baseline] −1.24, 1.07; per protocol analysis: 95% CI −1.42, 1.09). No significant differences
were found in secondary outcomes.
Conclusion: We were unable to detect any differences between the newborn wash product and water. These findings
provide reassurance to parents who choose to use the test newborn wash product or other technically equivalent
cleansers and provide the evidence for health care professionals to support parental choice.
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I nfant skin has several important functions, in-cluding prevention of infection, maintenance of
a stable water content level, and reduction of the
penetration of allergens and irritants (Holbrook,
2000). These functions depend on the mainte-
nance of an effective skin barrier with an optimum
pH (Cork et al., 2008). A neonate’s skin remains
immature for some time following birth; it has been
demonstrated that the stratum corneum continues
to develop until at least age 12 months (Nikolovski,
Stamatas, Kollias, & Wiegand, 2008). The normal
skin pH at the surface of the stratum corneum af-
ter the first year of life is around 5.5. This low pH
is important for maintaining low protease activity
and enhancing the synthesis of the lipid lamellae,
which are central to the maintenance of a normal
skin barrier (Danby & Cork, 2011).
The most common skin diseases during this first
year of life are napkin/diaper dermatitis, skin in-
fections, and atopic dermatitis (AD) (Atherton &
Mills, 2004). Atopic dermatitis occurs as a result
of gene–environment interactions leading to skin
barrier breakdown (Cork et al., 2009). Soap and
harsh surfactants play an important role in facili-
tating skin barrier deterioration and triggering AD
onset (Danby & Cork, 2011). The optimal wash
product for a neonate should have a pH around
5.5 and some buffering capacity to maintain skin
pH around this level. This was the pH of the wash
product used in this trial. At the other end of the
spectrum, a soap bar can raise the pH of the skin
above 8.0. This leads to enhanced protease activ-
ity and inhibits the synthesis of the lipid lamellae,
resulting in breakdown of the skin barrier (Cork
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et al.; Danby & Cork). When oils are reacted with
a solution of sodium hydroxide, they break down
to form glycerol and the sodium salts of their
fatty acids. These salts are used as soap, which
are an example of an anionic surfactant. Surfac-
tants have varying effects on skin barrier integrity
(Goffin, Paye, & Pie´rard, 1995). Surfactants with
a negative charge (e.g., sodium dodecyl [lauryl]
sulphate) have greater skin irritation potential com-
pared with glycosylated surfactants (Ananthapad-
manabhan, Moore, Subramanyan, Misra, & Meyer,
2004), the latter of which were used in the study
wash product.
Atopic dermatitis is a significant health care bur-
den and impairs the quality of life of infants (Lewis-
Jones, Finlay, & Dykes, 2001) and their parents
(Lawson, Lewis-Jones, Finlay, Reid, & Owens,
1998). Such problems highlight the need for suit-
able skin care regimens. As a result, water alone
has been suggested as the least harmful method
for newborn cleansing in many countries (National
Institute for Health and Clinical Excellence [NICE],
2006). However, the buffering capacity of water
has been questioned, as it may increase the skin
surface pH from 5.5 to 7.5 (Tsai & Maibach, 1999).
A pH of 7.5 is likely to increase skin protease ac-
tivity and inhibit the synthesis of the lipid lamellae,
leading to a breakdown of the skin barrier (Tsai &
Maibach). Water alone has been identified as an
ineffective cleanser, as it fails to remove fat-soluble
substances such as feces and sebum (Gelmetti,
2001). This is an issue highlighted as particularly
important by mothers (Lavender et al., 2009).
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Although guidelines exist for the treatment of
atopic eczema (NICE, 2007), there are no guide-
lines for primary prevention of atopic eczema.
Within the United Kingdom, national postnatal care
guidelines recommend bathing with water alone in
the early postnatal period (NICE, 2006). However,
neonatal skin care guidelines in the United States
(Lund et al., 2007) recommend the use of warm
tap water for bathing with the option to use a mild
cleanser that has a neutral pH (5.5 to 7.0). The ab-
sence and inconsistencies in guidelines are likely
to be the result of a dearth of robust evidence
from which to inform practice. [Correction added
after online publication 19 Feb 2013: In the pre-
vious two paragraphs, the NICE references were
erroneously listed as “NIHCE.” This has been cor-
rected here and in the reference list.]
In a recent systematic review (Crozier & Macdon-
ald, 2010) of newborn cleansing products versus
water, of nine studies identified, only two were el-
igible for inclusion. A meta-analysis was not car-
ried out because of the heterogeneity of trial pro-
tocols. The first study by Garcia Bartels et al.
(2010) included 64 full-term newborns in Berlin
and aimed to test the hypothesis that twice-weekly
bathing with a commercially available wash gel
and additional cream would not harm the natural
adaptation of the skin barrier in healthy newborns.
Participants were randomized to one of the four
following trial arms: bathing twice weekly with
commercially available wash gel product; bathing
twice weekly with clear water, then applying a
commercially available body cream; bathing with
wash gel and applying cream after bathing; and
bathing with clear water only. The second study
included in the systematic review (Dizon, Gal-
zote, Estanislao, Mathew, & Sarkar, 2010) was a
three-armed trial conducted in the Philippines,
which compared two different liquid cleansers
with water alone; 60 infants were randomized in
each arm. Authors of both studies concluded that
neonatal skin barrier function was not harmed
by the tested skin care regimens in healthy, full-
term infants. However, neither provided an a pri-
ori primary outcome or sample size, nor did they
follow the Consolidated Standards of Reporting
Trials (CONSORT) guidelines (Begg et al., 1996)
for reporting. Thus, the authors of the systematic
review concluded that there is currently insufficient
evidence on which to base practice.
The absence of adequately powered randomized
trials led us to develop a research program to ex-
amine whether a bathing product formulated for
infants is appropriate for newborn bathing. First,
a qualitative study exploring the views of women
and health professionals on bathing regimens, in
one U.K. setting, was conducted (Lavender et al.,
2009). This study confirmed the inconsistencies in
bathing practices and the readiness of women to
use bathing products. We then conducted a pi-
lot randomized, controlled trial (Lavender et al.,
2011) comparing a newborn bathing product with
water alone. The aim of the pilot study was to in-
form decisions for the main trial design and to op-
timize the robustness of trial processes. The pilot
study confirmed that the primary outcome mea-
sure (transepidermal water loss [TEWL]) was fea-
sible. However, no trends in the data were found in
any direction or on any site of the body. Therefore,
we have proceeded with a noninferiority trial to test
the hypothesis that the use of a wash product for-
mulated for newborn (<1 month of age) bathing is
not inferior (no worse) to bathing with water only.
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Methods
Ethical approval was obtained from the Cheshire
Research Ethics Committee. All participants gave
written and verbal consent to participate. Between
February 2010 and March 2011, we recruited
healthy newborn infants born at 37 weeks gesta-
tion or more from a teaching hospital in the North-
west of England. We excluded infants if they were
admitted to the neonatal unit; were receiving pho-
totherapy; had limb defects, nontraumatic impair-
ment of epidermal integrity, or evidence of skin
disorder at first visit. We also excluded infants with
a chromosomal abnormality or other syndromic di-
agnosis and infants going for adoption.
Pregnant women of potentially eligible infants were
supplied study information in the antenatal period
via community and hospital clinics. In the postna-
tal period, the attending clinical midwives sought
verbal permission for a research midwife to ap-
proach women who had been given prior infor-
mation. The research midwife collected baseline
details from all women supplying verbal and writ-
ten consent, using a self-administered question-
naire. Family history of atopic eczema also was
established at this stage (defined as at least one
of father, mother, or sibling who has had a medical
diagnosis of atopic eczema and who has had top-
ical steroid treatment). Interpreters were available
for non-English speaking women.
Randomization and Follow-Up
Infants were randomized to a bathing regimen us-
ing a newborn wash product or water alone be-
fore their first bath. Randomization was by con-
secutively numbered, sealed, opaque envelopes
held by the research manager at the study hos-
pital. The randomization sequence was in uneven
blocks and stratified according to whether there
was a family history of atopic eczema. All women
were given written instructions on how to bathe
their infants. Parents were requested not to use
any additional products, such as oils, sponges,
and wipes. Participating mothers were instructed
to bathe their neonate at least 3 times per week
and to avoid rubbing of the skin. Those allocated
to bathe their neonate in water alone (control) were
not provided with any products. If these moth-
ers wished to use shampoo on their neonates’
hair, they were requested to do this outside of
the bath, and to ensure that the neonate’s body
was wrapped in a towel, to prevent contact with
the skin. Those allocated to the wash product (ex-
perimental) were provided with sufficient newborn
wash and advised to dilute the product at a ratio
Mothers have expressed concern that water alone is an
ineffective cleanser, but evidence on appropriate newborn
bathing has been insufficient to inform practice.
of three squirts per bath. On the day of assess-
ment, mothers were requested to delay bathing
their neonate until measurements had been taken.
The chosen commercially available wash prod-
uct, Johnson’s Baby Top-to-Toe Bath (Johnson
& Johnson Limited, Maidenhead SL6 3UG, UK),
is a soap-free liquid cleanser designed for new-
borns’ skin. It is sodium lauryl sulphate-free and
consists of a proprietary blend of nonionic and
amphoteric surfactants that when combined re-
sult in large micelles that clean via dispersal of
fats without disrupting the skin barrier. The for-
mula contains well-tolerated preservatives and a
low level of fragrance; it is pH-adjusted (around
5.5) and hypoallergenic. The International Nomen-
clature Cosmetic Ingredients list comprised aqua,
coco-glucoside, cocamidopropyl betaine, citric
acid, Acrylates/C10–30 Alkyl Acrylate Crosspoly-
mer, sodium chloride, glyceryl oleate, p-Anisic
acid, sodium hydroxide, phenoxyethanol, sodium
benzoate, and parfum.
Outcome Measures
We planned to examine objective markers of skin
integrity that are sensitive enough to detect sub-
clinical changes in skin barrier function. Our pilot
trial established that obtaining baseline measure-
ments in hospital and follow-up outcome measure-
ments at home was feasible and acceptable to
mothers (Lavender et al., 2011). On the basis of
our pilot trial and previous work in this field, the
primary outcome was based on measurements
of TEWL, which is a measure of the flux of wa-
ter vapor evaporating from the skin surface. This
technique provides an overall marker of how an
intervention or development affects the function
of the skin as a barrier to water loss (Flohr et al.,
2010); lower values represent a good skin bar-
rier. This technique is noninvasive and has been
measured in preterm and term neonates (Agren,
Sjo¨rs, & Sedin, 2006; Harpin & Rutter, 1983) and
older infants (Nikolovski et al., 2008). The primary
outcome measure was the average of TEWL mea-
surements, using a closed chamber system, over
three sites (outer forearm, midpoint between wrist
and elbow; front of thigh, midpoint between knee
and groin; abdomen, midpoint between umbili-
cus and sternum) at 14 days following birth us-
ing an AquaFlux Model AF200 (Biox Systems Ltd,
JOGNN 2013; Vol. 42, Issue 2 205
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London, UK). The pilot study (Lavender et al.,
2011) found no important differences in TEWL
measurements between body parts; therefore, we
analyzed an average assessment score.
Secondary outcomes comprised TEWL at 4
weeks postbirth, skin surface pH using a
Courage + Khazaka Skin-pH-Meter R© PH 900,
and stratum corneum hydration scores using
Corneometer R© CM 820 (Courage + Khazaka elec-
tronic GmbH, Cologne, Germany) from baseline
(within 48 hours of birth). Because of the sensi-
tivity of the neonate’s skin in the early weeks fol-
lowing birth, this is an ideal time to investigate the
effect of wash products. Any differences in these
outcomes are likely to be greater than later in an
infant’s life when the skin barrier is more stable.
These secondary outcomes were measured at 2
and 4 weeks postbirth. Anatomical markers were
used to ensure assessments were consistent. Two
measurements were taken at each site; mean
scores were used in analysis. Skin measurement
instruments were calibrated before recruitment,
during the recruitment period, and following the
last follow-up assessment.
Clinical measures comprised observations of the
skin daily by the mother from first assessment
to 4 weeks postbirth; a semistructured diary was
used to record observations. Observations were
made by the midwife at the times of assess-
ment and were recorded with the aid of a vali-
dated skin assessment scale (Lund & Osborne,
2004) that included a scale for erythema, excori-
ation, and dryness. For each component an aver-
age grade was obtained across body parts. This
scale has been used in a number of compara-
tive studies (Brandon, Coe, Hudson-Barr, Oliver, &
Landerman, 2010; Garcia Bartels et al., 2011).
Mothers’ satisfaction with their allocated cleans-
ing regimen was obtained using a specifically
designed questionnaire that had been evaluated
for content validity through earlier qualitative work
(Lavender et al., 2009).
Blinding
The research midwives carrying out the mea-
surements were blinded to treatment allocation.
Women were asked not to reveal their allocation to
the midwife assessing the neonate in their home.
The research assistant telephoned women on the
day of assessment to remind them to remove
visible signs of products prior to the midwife’s
arrival.
Compliance
To optimize compliance levels, weekly telephone
contact with participating women was maintained.
Participants were requested to keep a cleansing
diary for the study duration. It was prespecified
that we would assess the impact of any noncom-
pliance on the primary outcome using five cate-
gories. Strict compliance was defined as nonuse
of any additional products on the areas of the body
under assessment or any products likely to cause
contamination (e.g., talcum powder). Mostly com-
pliant and partially compliant were defined as the
nonuse of additional products in the week before
the assessment, with no more than two product
deviations and more than two product deviations,
respectively. Rarely compliant and noncompliant
were defined as use of additional products on the
areas of the body being measured or any products
likely to cause contamination during the week of
assessment with no more than two product de-
viations and more than two product deviations,
respectively.
Statistical Analysis
Data were analyzed using Stata 11 (StataCorp LP,
College Station, TX) following double entry of all
data, with the statistician blinded to the true treat-
ment allocation. Two data sets were defined that
were used for analysis. The intention-to-treat (ITT)
data set includes all the participants who have
data for the primary outcome. The per protocol
(PP) data set excludes participants satisfying ITT
who were classified as rarely compliant or non-
compliant.
Preliminary analysis compared the demographic
and baseline characteristics of participants be-
tween treatment groups, further stratifying by fam-
ily history of atopic eczema. A prespecified linear
model was used to estimate the effect of treat-
ment on the primary and secondary outcomes,
adjusting for family history of eczema, baseline
outcome, and state of neonate (awake and calm,
asleep, crying) at baseline and follow-up. Prelimi-
nary blinded analysis suggested that the neonatal
state may influence the outcome measurements;
in particular, crying, which may be indicative of
stress, is associated with movement and can af-
fect skin surface temperature (Rogiers & EEMCO,
2001). Clinical outcomes were summarized by
percentages and compared using odds ratios ad-
justed for randomization strata and associated
p values. Maternal views of the intervention were
compared between groups using Fisher’s exact
test or t test.
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Figure 1. Participant flow during the study.
Multiple sensitivity analyses were carried out to
test the effect of data and analysis assumptions
and where any imbalance in demographic or
baseline data was found.
One extreme outlying TEWL value (255) was as-
sumed to be an instrument error and was treated
as missing. Four neonatal states were missing at
the 2-week follow-up and were assumed to be
awake and calm. Sensitivity analysis investigated
to what extent these assumptions affected the re-
sults. All significance levels are presented without
adjustment for multiple testing.
Sample Size
Based on the pilot data, we estimated that a non
important inferiority in TEWL would be 1.2. The up-
per limit of subclinical difference was determined
JOGNN 2013; Vol. 42, Issue 2 207
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by experienced clinicians on the trial management
group and Data Monitoring Committee. Assuming
a common standard deviation is 3 and allowing
for a very small actual difference of up to 0.2 units,
favoring water, a sample size of between 100 and
140 per group would have 80% power to reject the
null hypothesis that the test and standard are not
equivalent (the average TEWL value for product is
at least 1.2 units greater than that for water), based
on a two-group, 2.5%, one-sided t test. Assuming
a 10% dropout over 4 weeks, and an actual differ-
ence of 0.1 units we aimed for 120 completers per
group by recruiting at least 133 participants per
group at baseline. Because the loss to follow-up
was greater than anticipated, we over-recruited to
compensate.
Results
Overall, 307 infants were randomized and the par-
ticipation rate was 22.4% (307/1372). The over-
all loss to first follow-up was 65/307 (21.2%); 33
(10.7%) in the wash group and 32 (10.4%) in the
water group. Participant flow can be seen in Fig-
ure 1. By first follow-up, 109/159 participants in
the wash group were strictly compliant with the
study protocol, 10 were mainly compliant, 3 were
partially compliant, 9 were rarely compliant, and
4 were noncompliant; one participant complied
with the wrong treatment allocation. In the water
group, 92/148 participants were strictly compliant,
11 were mainly compliant, 5 were partially compli-
ant, 9 were rarely compliant, and 3 were noncom-
pliant; one participant complied with the wrong
treatment allocation. Similar baseline characteris-
tics (Table 1) and all first skin assessment mea-
sures also were comparable between randomized
groups (Table 2).
Primary Analysis
There was very little difference between the wash
and water groups in terms of TEWL (Table 3), and
the upper limit of the 95% confidence interval of
the difference did not reach the prespecified non-
inferiority margin. The location of the 95% con-
fidence interval (CI) in relation to the prestated
noninferiority value shows that the study was ad-
equately powered. Following the primary analy-
sis, sensitivity analysis was carried out including
the one outlying TEWL value (deemed to be an
instrument error); excluding the four with miss-
ing neonatal state (assumed to be awake and
calm); excluding all crying infants, further adjust-
ing for shampoo and detergent use at first follow-
Table 1: Baseline Characteristics of Partici-
pants by Randomized Group
Characteristic Wash Water
(n = 159) (n = 148)
Family history of atopic eczema 42 (27) 42 (29)
Maternal age (years), mean (SD) 28.6 (5.6) 28.2 (6.1)
Maternal ethnicity
White, British 128 (81) 132 (89)
Black and ethnic minority 16 (10) 14 (10)
Other 15 (9) 2 (1)
Maternal parity
Primiparous 79 (50) 76 (51)
Multiparous 80 (50) 72 (49)
Birth mode
Normal vaginal 115 (72) 99 (67)
Instrumental 20 (13) 25 (17)
Caesarean section 22 (14) 24 (16)
Vaginal breech 2 (1) 0 (0)
Infant’s gender
Male 80 (50) 78 (53)
Female 79 (50) 70 (47)
Birth weight, g 3435 (429) 3445 (525)
Feeding method
Breast 65 (41) 53 (36)
Bottle 76 (48) 80 (54)
Mixed 18 (11) 15 (10)
Note. Values are n (%) unless stated otherwise.
Table 2: First Skin Assessments by Ran-
domized Group
Measurement, mean (SD) Wash Water
(n = 159) (n = 148)
TEWL (g/m2/h) 13.1 (3.4) 13.3 (3.6)
Hydration (arbitrary units) 37.6 (9.4) 36.1 (10)
Skin pH 6.2 (0.6) 6.2 (0.6)
Note. TEWL = transepidermal water loss.
up; and for the PP analysis only including strictly
compliant (the five level compliance definition)
(Figure 2). None of these analyses substantially
altered the results.
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Table 3: Comparison of Primary Outcome Measure (TEWL) at Follow-Up by Randomized
Group Under ITT and PP Analyses
Analysis Wash (n = 126) Water (n = 116) Wash–water adjusted difference p-value
Mean (SD) Mean (SD) in means (95% CI)a
ITT 12.8 (4.5) 12.5 (5.6) −0.08 (−1.24, 1.07)a .89
PP 12.8 (4.6) 12.6 (5.9) −0.17 (−1.42, 1.09)a .79
Note. CI = confidence interval; ITT = intention-to-treat; PP = per protocol; TEWL = transepidermal water loss.
aControlling for family history of eczema, infant state at 2 weeks and baseline, and baseline TEWL.
Secondary Analyses
Tables 4, 5, and 6 present the secondary out-
comes that detail the biophysical assessment,
clinical observations, and maternal views.
Biophysical Assessments. Skin assessment re-
sults are presented in Table 4. No significant dif-
ferences were found in the pH measurements at
14 days, as well as no significant difference in
TEWL at 28 days. Differences were found in stra-
tum corneum hydration that was higher in the wash
group at 14 days. However, after adjustment for
multiple testing, this difference would not be con-
sidered statistically significant and was reduced
at 28 days.
Clinical Observations. Clinical observation results
are presented in Table 5. Observations of dry and
very dry skin were merged for analysis because of
the limited information that the very dry category
held. No significant differences between groups
were found when observing for dryness or ery-
thema, and no excoriation was observed in either
group.
Maternal Views. Mothers’ perception of their al-
located skin regimen, gathered using diaries
for the intervention period and questionnaires
at 8 weeks, are presented in Table 6. Two-
hundred-and-ten participants responded; 68.4%
of the initial 307 in the trial. The response was
Figure 2. Sensitivity analyses: 95% confidence interval for difference in TEWL score at 2 weeks between groups for a number of
different alternative assumptions and analyses. ITT = intention-to treat; PP = per-protocol; TEWL = transepidermal water loss.
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Table 4: Comparison of Secondary Biophysical Outcomes at Follow-Up by Randomized
Group (ITT Analyses)
Analysis, mean (SD) Wash Water Wash–water adjusted difference p value
(n = 126) (n = 116) in means (95% CI)a
14 Days
pH 5.5 (0.5) 5.5 (0.5) 0.05 (−0.07, 0.17) .40
Hydration 49.7 (9.2) 46.7 (8.4) 2.9 (0.43, 5.47) .022
28 Days
TEWL 12.6 (5.2) 13.6 (5.4) −0.90 (−2.20, 0.40) .17
pH 5.8 (0.5) 5.3 (0.4) 0.03 (−0.09, 0.16) .60
Hydration 54.1 (9.9) 54.7 (9.3) 2.4 (−0.40, 5.20) .093
Note. CI = confidence interval; ITT = intention-to-treat; TEWL = transepidermal water loss.
aControlling for family history of eczema, infant state at 2 weeks and baseline, and baseline TEWL.
representative of the original sample, with ap-
proximately 53% in the product arm and 47% in
the water arm (compared with 52% and 48% in
the original sample). Differences between groups
were only found in two items assessed by moth-
ers. Mothers were more likely to state that using a
bathing product left their neonate smelling good
(p < .001). This echos the findings of previous
qualitative work, in which mothers indicated that
smell was a factor in product choice (Lavender
et al., 2009). Mothers in the wash group who con-
tinued their allocated regimen post 28 days were
more likely to maintain the same bathing regimen
following study completion (p = .010). There were
no differences in overall satisfaction scores, as as-
sessed by a 10-cm visual analog scale.
Table 5: Comparison of Clinical Observations by Randomized Group (ITT Analyses)
14 Days OR (95% CI)a p-value 28 Days OR (95% CI)a p value
Product Water Product Water
n = 126 n = 116 n = 126 n = 104
n (%) n (%) n (%) n (%)
Dryness None 74 (58.73) 56 (48.28) 0.66b (0.40, 1.09) .11 102 (80.95) 93 (89.42) 1.74 (0.79, 3.82) .17
Dry 47 (37.30) 56 (48.28) 21 (16.67) 11 (10.58)
Very dry 4 (3.17) 2 (1.72) 0 (0.00) 0 (0.00)
Missing 1 (0.79) 2 (1.72) 3 (2.38) 0 (0.00)
Erythema None 116 (92.06) 98 (84.48) 0.46 (0.20, 1.05) .07 111 (88.10) 92 (88.46) 0.83 (0.36, 1.93) .66
<50% body 9 (7.14) 16 (13.79) 12 (9.52) 11 (10.58)
surface
>50% body 0 (0.00) 0 (0.00) 0 (0.00) 1 (0.96)
surface
Missing 1 (0.79) 2 (1.72) 3 (2.38) 0 (0.00)
Note. CI = confidence interval; ITT = intention-to-treat; OR = odds ratio.
aWash relative to water.
bDry and very dry skin data combined.
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Table 6: Maternal Views of Bathing Regimen (ITT Analyses)
Product (n = 111) Water (n = 99) Fisher’s Exact
n (%) n (%) p value
Smell <0.001
Made infant smell nice 73 (65.77) 26 (26.26)
Made no difference 38 (34.23) 68 (68.69)
Made infant smell unpleasant 0 (0.00) 5 (5.05)
Missing 0 (0.00) 0 (0.00)
Cleanliness 0.59
Cleaned adequately 97 (87.39) 76 (76.77)
Did not clean adequately 7 (6.31) 8 (8.08)
Made no differencea 6 (5.41) 0 (0.00)
Missing 1 (0.90) 15 (15.15)
Dryness 0.66
Made skin more dry 8 (7.21) 10 (10.10)
Made no difference 65 (58.56) 53 (53.54)
Made skin less dry 38 (34.23) 36 (36.36)
Missing 0 (0.00) 0 (0.00)
Would participate in trial again 0.87
Yes 107 (96.40) 95 (95.96)
No 1 (0.90) 2 (2.02)
Unsure 3 (2.70) 2 (2.02)
Missing 0 (0.00) 0 (0.00)
Recommend method of bathing to a friend? 0.47
Yes 95 (85.59) 86 (86.87)
No 6 (5.41) 8 (8.08)
Unsure 10 (9.01) 5 (5.05)
Missing 0 (0.00) 0 (0.00)
Quality of trial Information 1.0
Good 101 (90.99) 91 (91.92)
Adequate 10 (9.01) 8 (8.08)
Poor 0 (0.00) 0 (0.00)
Missing 0 (0.00) 0 (0.00)
Still using the same regimen? 0.14
Yes 80 (72.07) 62 (62.63)
No 30 (27.03) 37 (37.37)
Missing 1 (0.90) 0 (0.00)
If so, do you intend to continue regimen? 0.010
Yes 67 (60.36) 41 (41.41)
No 7 (6.31) 16 (16.16)
Data not requiredb 7 (6.31) 5 (5.05)
Missing 30 (27.03) 37 (37.37)
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In the largest randomized trial of healthy newborns, no
differences were found between using a specified proprietary
wash product and using water alone.
Discussion
We reported findings from the largest random-
ized clinical trial of healthy newborn infants and
bathing, demonstrating that the cleansing prod-
uct tested in our trial is not inferior (no worse) to
bathing with water alone, as assessed by TEWL.
Maintenance of correct water balance is one of
the key functions of the epidermis (Harpin & Rut-
ter, 1983; Hoath & Narendran, 2001). Increased
TEWL precedes the development of AD in those
with a genetic predisposition to the development
of AD and is therefore a clinically relevant mea-
sure (Flohr et al., 2010). Despite stratifying for a
family history of atopic eczema, we found no dif-
ference in TEWL measurements between those
bathed in water alone or with a cleansing prod-
uct, offering reassurance that the cleansing prod-
uct was not influencing skin barrier integrity. This
study demonstrates that the product tested in this
trial is acceptable and safe for use on newborn
skin.
In our earlier work (Lavender et al., 2011), moth-
ers raised concerns regarding skin dryness; this
was not raised as an issue in this trial. Although
there are known changes in hydration as the in-
fants’ skin matures (Nikolovski et al., 2008), this
was a randomized, controlled trial; and these
changes were expected to be similar between trial
groups. Stratum corneum hydration was higher
in the wash group at 14 days, which appears
significant on an unadjusted basis; however, this
difference would not be considered statistically
significant after adjustment for multiplicity. Fur-
thermore, any differences observed had disap-
peared by 28 days, suggesting that this may be
an unimportant or even a chance finding. This
is an area that warrants further study, especially
as bathing the skin in water may elute out natu-
ral moisturizing factor (NMF) from the skin. Nat-
ural moisturizing factor has an important role as
a humectant, retaining water within the stratum
corneum. Natural moisturizing factor also contains
several acids, including lactic acid, urocanic acid,
and sodium pyrrolidone carboxylic acid. These
acids keep the pH of the stratum corneum low,
which is important for the maintenance of the nor-
mal skin barrier. In order to reduce the eluting of
NMF from the stratum corneum, bathing should
be restricted to the shortest period possible (e.g.,
5 minutes).
Overall, maternal satisfaction between trial arms
showed no differences. However, importantly,
more than two thirds of women who were allo-
cated to the wash group were still using their allo-
cated regimen at 8 weeks postbirth. Of these, 60%
intended to continue with this regimen, suggest-
ing satisfaction with the product. Moreover, it con-
firms our earlier findings (Lavender et al., 2009)
that many parents prefer to use bathing prod-
ucts versus water alone. These findings offer evi-
dence to recommend that parents should be sup-
ported to use their preferred method of neonatal
bathing.
We found no evidence of harm with the use of
the product evaluated in this study. These find-
ings resonate with those of other recent trials (Di-
zon et al., 2010; Garcia Bartels et al., 2010) that
also failed to find evidence of harm when us-
ing modern cleansing products. Unlike the pre-
vious studies, this trial stated an a priori pri-
mary outcome, ensured the study was adequately
powered, and was distinguished from previous
work by quality and sample size. Our work is a
significant advancement in the evaluation of skin
care in the month after birth.
Table 6: Continued
Mean (SD) Mean (SD) t test
Satisfaction rating 0.15
10 cm visual-analogue scale 9.12 (1.52) 8.82 (1.56)
Missing 2 (1.80%) 1 (1.01%)
Note. ITT = intention-to-treat.
aThis category was omitted from the statistical comparison as its meaning is ambiguous.
bData was not required for the 67 participants who answered “no” to “same regimen.”
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This study was conducted in one hospital set-
ting. Nevertheless, this setting supports women
from diverse sociocultural backgrounds and our
data reflect this; findings are likely to be transfer-
able to other settings. However, further research
may be needed in settings where cultural prac-
tices, environmental conditions, or water condi-
tions are different; all of which may influence TEWL
measurements.
Parents are faced with a multitude of commercial
products and have to navigate the complex in-
gredient information and influential branding be-
fore making purchasing choices. Although the
choice of products can vary around the world,
certain minimum criteria should be met when
they are indicated for use in newborns and in-
fants. These include not only appropriateness of
pH, around 5.5, and documented skin safety,
but also more importantly, ocular safety because
cleansers can often be inadvertently splashed into
a neonate’s developing eyes during routine use.
Increasingly, parents are seeking the evidence to
support their child care practices, evidenced by
the increasing numbers of websites and parental
“hits.” The term clinically tested, which appears
on many neonatal products, covers a range of
testing and fails to provide accurate detail on the
rigor of such investigations. New regulations are
needed to cover the claims that can be made for
a particular product in relation to the quality of
the clinical trial evidence. This would allow par-
ents to identify the best products and encourage
companies to invest in producing the best for-
mulations and evaluating them in appropriately
powered clinical trials. In our opinion, to ensure
that truly informed decisions are made, parents
should be informed of neonatal products that have
been tested in robust randomized clinical trials.
Nurses and midwives have a key role in provid-
ing such information during parent education ses-
sions. Nurses have a professional responsibility
to critique new evidence, which sometimes su-
persedes national guidelines, particularly when
the guidelines have been based on low levels of
evidence.
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